These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 9627814

  • 1. Adolescent satisfaction with postpartum contraception and body weight concerns.
    Hellerstedt WL, Story M.
    J Adolesc Health; 1998 Jun; 22(6):446-52. PubMed ID: 9627814
    [Abstract] [Full Text] [Related]

  • 2. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
    Polaneczky M, Liblanc M.
    J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
    [Abstract] [Full Text] [Related]

  • 3. Depo Provera: a profile of current users.
    Jarman H, Kovacs GT, Westcott M.
    Aust N Z J Obstet Gynaecol; 1990 Feb; 30(1):74-6. PubMed ID: 2140675
    [Abstract] [Full Text] [Related]

  • 4. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R, Hales HA, Stevenson K, Hatasaka HH, Poulson AM, Jones KP, Peterson CM.
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [Abstract] [Full Text] [Related]

  • 5. Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department.
    Potter LS, Dalberth BT, Cañamar R, Betz M.
    Contraception; 1997 Nov; 56(5):305-12. PubMed ID: 9437559
    [Abstract] [Full Text] [Related]

  • 6. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z.
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [Abstract] [Full Text] [Related]

  • 7. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.
    Lei ZW, Wu SC, Garceau RJ, Jiang S, Yang QZ, Wang WL, Vander Meulen TC.
    Contraception; 1996 Jun; 53(6):357-61. PubMed ID: 8773423
    [Abstract] [Full Text] [Related]

  • 8. Depo Provera: still controversial.
    Wren LM.
    Int Health News; 1988 Feb; 9(2):2-3, 8. PubMed ID: 12179873
    [Abstract] [Full Text] [Related]

  • 9. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
    Harel Z, Biro FM, Kollar LM, Rauh JL.
    J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083
    [Abstract] [Full Text] [Related]

  • 10. Depo-Provera in adolescents: effects of early second injection or prior oral contraception.
    Harel Z, Biro FM, Kollar LM.
    J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688
    [Abstract] [Full Text] [Related]

  • 11. Are Norplant, Depo-Provera good options for nursing mothers?
    Contracept Technol Update; 1993 Mar; 14(3):46-8. PubMed ID: 12318085
    [Abstract] [Full Text] [Related]

  • 12. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.
    Moore LL, Valuck R, McDougall C, Fink W.
    Contraception; 1995 Oct; 52(4):215-9. PubMed ID: 8605778
    [Abstract] [Full Text] [Related]

  • 13. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
    Cromer BA, Smith RD, Blair JM, Dwyer J, Brown RT.
    Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
    [Abstract] [Full Text] [Related]

  • 14. Forearm bone density in users of Depo-Provera as a contraceptive method.
    Bahamondes L, Perrotti M, Castro S, Faúndes D, Petta C, Bedone A.
    Fertil Steril; 1999 May; 71(5):849-52. PubMed ID: 10231044
    [Abstract] [Full Text] [Related]

  • 15. Teens and Depo-Provera: a good match?
    Contracept Technol Update; 1995 Jul; 16(7):86-8. PubMed ID: 12346507
    [Abstract] [Full Text] [Related]

  • 16. Contraception update: implantable and injectable methods.
    Gold MA.
    Pediatr Ann; 1995 Apr; 24(4):203-7. PubMed ID: 7596649
    [Abstract] [Full Text] [Related]

  • 17. Timing of onset of contraceptive effectiveness in Depo-Provera users: Part I. Changes in cervical mucus.
    Petta CA, Faundes A, Dunson TR, Ramos M, DeLucio M, Faundes D, Bahamondes L.
    Fertil Steril; 1998 Feb; 69(2):252-7. PubMed ID: 9496338
    [Abstract] [Full Text] [Related]

  • 18. Depo-Provera: just another contraceptive?
    Jones M.
    Fertil Contracept; 1978 Apr; 2(2):26-9. PubMed ID: 12336094
    [Abstract] [Full Text] [Related]

  • 19. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [Abstract] [Full Text] [Related]

  • 20. Depressive symptoms and Depo-Provera.
    Westhoff C, Truman C, Kalmuss D, Cushman L, Davidson A, Rulin M, Heartwell S.
    Contraception; 1998 Apr; 57(4):237-40. PubMed ID: 9649914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.